Company Directory

Company Directory

Company Directory - Fujirebio

Company Details - Fujirebio

Fujirebio Logo

Fujirebio

Fujirebio is a global R&D-driven company specializing in in vitro diagnostics testing solutions. The company develops innovative diagnostic tests and instruments used in clinical laboratories worldwide for disease detection and monitoring.

CCI Score

CCI Score: Fujirebio

5.76

-0.01%

Latest Event

Fujirebio Supply Chain Enhancement Partnership with Kinaxis

Fujirebio Inc. has implemented Kinaxis' Maestro platform to optimize its supply chain operations, enhancing transparency and efficiency from raw material sourcing to final product shipment. Although the announcement does not explicitly address labor or forced labor concerns, the improved orchestration may indirectly promote more ethical supply chain management.

Take Action

So what can you do? Support by shopping, spreading the word, or offering your support.

Use Your Voice
OTHER TOOLS
Investigate
Share the Score
SUPPORT CCI

OBJECTOR

Fujirebio is currently rated as an Objector.

0 to +9 CCI Score
These companies deliberately avoid direct involvement with authoritarian practices. While they do not actively challenge oppressive regimes, they maintain a neutral stance to ensure they are not complicit in supporting such systems.

Latest Events

  • Fujirebio Supply Chain Enhancement Partnership with Kinaxis Logo
    MAR
    19
    2025

    Fujirebio Inc. has implemented Kinaxis' Maestro platform to optimize its supply chain operations, enhancing transparency and efficiency from raw material sourcing to final product shipment. Although the announcement does not explicitly address labor or forced labor concerns, the improved orchestration may indirectly promote more ethical supply chain management.

  • +30

    Supply Chain Ethics

    March 20

    Fujirebio’s deployment of Kinaxis’ AI-powered supply chain orchestration platform indicates a strategic move to enhance supply chain transparency and efficiency. While the news does not delve into labor rights or explicit ethical sourcing policies, the integration of advanced technology in supply chain management can reduce vulnerabilities related to opaque sourcing practices, offering a modest positive step in ethical business practices.

    Fujirebio Enhances Supply Chain Operations with Kinaxis

  • Fujirebio Diagnostics Lobbying Activity Logo
    JAN
    01
    2015

    Fujirebio Diagnostics spent $10,000 on lobbying efforts in 2015, raising concerns about its influence on public policy and potential support for authoritarian practices. While the spending appears modest, from an anti-fascist perspective, any use of corporate funds to sway legislative actions warrants scrutiny.

  • -25

    Political Contributions and Lobbying Efforts

    March 20

    Fujirebio Diagnostics engaged in political lobbying by spending $10,000 in 2015. Although the amount is relatively modest compared to major industry spenders, this activity is concerning when viewed through an anti-fascist lens, as corporate lobbying can be used to influence legislation in ways that undermine democratic processes and support authoritarian agendas.

    Fujirebio Diagnostics Bills Lobbied • OpenSecrets

  • Fujirebio Diagnostics Lobbying Activity Logo
    JAN
    01
    2008

    OpenSecrets data highlights Fujirebio's engagement in lobbying activities. From an anti-fascist perspective, such political influence raises concerns about corporate complicity in fostering policy environments that may benefit authoritarian agendas.

  • -20

    Political Contributions and Lobbying Efforts

    March 20

    Fujirebio's lobbying activity, as reported by OpenSecrets, suggests the company is actively seeking to influence political processes. In an environment where corporate political engagement can undermine democratic safeguards, this activity is assessed as contributing to corporate complicity in supporting conditions favorable to authoritarian practices.

    Fujirebio Diagnostics Lobbying Profile • OpenSecrets

Industries

325413
In-Vitro Diagnostic Substance Manufacturing
541714
Research and Development in Biotechnology (except Nanobiotechnology)
621511
Medical Laboratories